Chemoinformaics analysis of 11beta,13-Dihydrolactucin
| Molecular Weight | 278.304 | nRot | 1 |
| Heavy Atom Molecular Weight | 260.16 | nRig | 16 |
| Exact Molecular Weight | 278.115 | nRing | 3 |
| Solubility: LogS | -2.472 | nHRing | 1 |
| Solubility: LogP | -0.325 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 41.0623 |
| nHD | 2 | BPOL | 21.5297 |
| QED | 0.703 |
| Synth | 4.616 |
| Natural Product Likeliness | 1.966 |
| NR-PPAR-gamma | 0.511 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.853 |
| HIA | 0.099 |
| CACO-2 | -4.998 |
| MDCK | 0.00000479 |
| BBB | 0.608 |
| PPB | 0.35958 |
| VDSS | 0.805 |
| FU | 0.471075 |
| CYP1A2-inh | 0.036 |
| CYP1A2-sub | 0.738 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.89 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.876 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.183 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.385 |
| CL | 2.72 |
| T12 | 0.241 |
| hERG | 0.023 |
| Ames | 0.13 |
| ROA | 0.498 |
| SkinSen | 0.16 |
| Carcinogencity | 0.06 |
| EI | 0.011 |
| Respiratory | 0.04 |
| NR-Aromatase | 0.868 |
| Antiviral | Yes |
| Prediction | 0.746401 |